In patients with venous thromboembolism (VTE) who are candidates for oral anticoagulation, apixaban results in fewer hospitalizations for recurrence and less major bleeding than rivaroxaban or ...

2. Eliquis (apixaban) by Bristol Myers Squibb and Pfizer — $18.95 billion Eliquis (apixaban) is an "anchor drug" for both BMS and Pfizer, according to Stanford.

News Release 31-Oct-2024 Apixaban vs aspirin in patients with cancer and cryptogenic stroke Peer-Reviewed Publication Ochsner Health System ...

Apixaban may be available through a mail-order pharmacy. Using this type of service may help lower the drug’s cost and allow you to receive your medication without leaving home. Some Medicare ...

Apixaban is a generic prescription drug that’s used to treat or prevent certain blood clots. Apixaban’s cost may depend on factors such as your dosage, whether you have health insurance, and ...

Apixaban, the generic form of Eliquis by Pfizer and Bristol Myers Squibb, maintained its status as the highest-costing drug to the NHS in England in the 2022/23 period. The drug was responsible for ...

The typical dosage of Eliquis for hip and knee replacement is 2.5 mg taken twice per day. You’ll take your first dose at least 12 to 24 hours before your scheduled surgery.

Key takeaways: Apixaban tied to less stroke and bleeding in patients with/without dementia vs. dabigatran, rivaroxaban or warfarin. This association was strongest for the outcome of major bleeding.

Eliquis is used to treat and prevent blood clots in certain people. Learn about its recommended dosages, how to take it, and more.

Compared with other direct oral anticoagulants, apixaban was associated with lower rates of gastrointestinal bleeding but similar rates of ischemic stroke and all-cause mortality among adults with ...

Apixaban was also associated with a 49% lower risk of gastrointestinal or intracranial bleeding vs rivaroxaban (HR, 0.51; 95% CI, 0.41-0.62).

More information: Ghadeer K. Dawwas et al, Apixaban Versus Rivaroxaban in Patients With Atrial Fibrillation and Valvular Heart Disease, Annals of Internal Medicine (2022). DOI: 10.7326/M22-0318 ...